Emerald to host 2020 year-end financial results conference call on Monday, May 3, 2021, at 10:30 AM ET

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald" or "the Company") has received final approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"). The Company will voluntarily delist its Common Shares from the TSX Venture Exchange (the "TSXV") after market close on Monday, April 26, 2021. The Common Shares will commence trading on the CSE under the same symbol, EMH, at market open Tuesday, April 27, 2021. Trading of the Common Shares in the US will continue unchanged on the OTCQX under the symbol EMHTF.

"As a key part of Emerald's go-forward strategy, we have a clear intent to move forward on opportunities in the US. Transferring our listing to the CSE allows us to take these steps without restriction, and we expect to take our first step imminently," said Riaz Bandali, President and CEO.

Year-end financial report and conference call

Emerald will report audited financial results for the fourth quarter and year ended December 31, 2020 after the market close on Friday, April 30, 2021. The company will host a conference call on Monday, May 3, 2021, at 10:30 a.m. ET. To access the audio broadcast, please dial (866) 652-5200, or via the internet at:
https://services.choruscall.com/links/emhtf210429.html

An archived version of the presentation will be available for 90 days on the "Investors" section of Emerald's website: https://emeraldhealth.ca/investors/events-and-presentations/

About Emerald Health Therapeutics

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and product excellence.

Please visit www.emeraldhealth.ca for more information or contact:

Jenn Hepburn, Chief Financial Officer
(800) 757 3536 Ext. #5

Emerald Investor Relations
(800) 757 3536 Ext. #5
invest@emeraldhealth.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements: Certain statements made in this press release that are not historical facts are forward-looking statements and are subject to important risks, uncertainties and assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements. Such statements include: the benefits of listing the Common Shares on the CSE; and the conduct of Emerald's business in other jurisdictions.

We cannot guarantee that any forward-looking statement will materialize, and readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements involve risks and uncertainties related to, among other things, changes of law and regulations; changes of government; failure to obtain regulatory approvals or permits; failure to obtain necessary financing; results of production and sale activities; regulatory changes; changes in prices and costs of inputs; demand for products; changes in business strategy; as well as the risk factors described in Emerald's annual information form and other regulatory filings. The forward-looking statements contained in this press release represent our expectations as of the date hereof. Forward-looking statements are presented for the purpose of providing information about management's current expectations and plans and allowing investors and others to obtain a better understanding of our anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes. Emerald undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81485